You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

nnc0194-0499

Showing 1 - 7 of 7
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Non-alcoholic Fatty Liver Disease Trial in Jinan (NNC0194-0499, NC0194-0499)

Not yet recruiting
  • Non-alcoholic Fatty Liver Disease
  • Jinan, Shandong, China
    Novo Nordisk Investigational Site
Feb 14, 2023

Non-alcoholic Steatohepatitis Trial in Montreal (NNC0194-0499, Semaglutide, NNC0194-0499/Semaglutide A (40/3.20 mg/mL))

Not yet recruiting
  • Non-alcoholic Steatohepatitis
  • NNC0194-0499
  • +3 more
  • Montreal, Quebec, Canada
    Novo Nordisk Investigational Site
Mar 9, 2023

Non-alcoholic Steatohepatitis (NASH) Trial in Berlin (NNC0194-0499)

Not yet recruiting
  • Non-alcoholic Steatohepatitis (NASH)
  • NNC0194-0499
  • Berlin, Germany
    Novo Nordisk Investigational Site
Feb 17, 2023

Hepatic Impairment, Healthy Volunteers Trial in München, Gdansk, Bratislava (NNC0194-0499)

Not yet recruiting
  • Hepatic Impairment
  • Healthy Volunteers
  • NNC0194-0499
  • München, Germany
  • +2 more
Jun 27, 2023

Non-alcoholic Steatohepatitis Trial in Tokyo (NNC0194-0499, Placebo (NNC0194-0499 ))

Completed
  • Non-alcoholic Steatohepatitis
  • NNC0194-0499
  • Placebo (NNC0194-0499 )
  • Tokyo, Japan
    Novo Nordisk Investigational Site
Apr 4, 2022

Metabolism and Nutrition Disorder, Obesity Trial in San Antonio (NNC0194-0499, Placebo)

Completed
  • Metabolism and Nutrition Disorder
  • Obesity
  • NNC0194-0499
  • Placebo
  • San Antonio, Texas
    Novo Nordisk Investigational Site
Jun 25, 2019

Metabolism and Nutrition Disorder, Obesity Trial in San Antonio (NNC0194-0499, Placebo)

Completed
  • Metabolism and Nutrition Disorder
  • Obesity
  • NNC0194-0499
  • Placebo
  • San Antonio, Texas
    Novo Nordisk Investigational Site
Sep 3, 2018